首頁 > 市場調查報告書 > 醫療設備

電子醫療設備

市場調查報告書

商品編碼

1539572

神經刺激設備市場規模、佔有率和成長分析：按類型、應用和地區分類 - 產業預測，2024-2031 年

Neurostimulation Devices Market Size, Share, Growth Analysis, By Type (Internal Neuromosulation, External Neuromosulation), By Application (Spinal Cord Stimulation, Deep Brain Stimulation), By Region - Industry Forecast 2024-2031

出版日期: 2024年08月16日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計2022年全球神經刺激設備市場規模為53億美元，從2023年的59.8億美元成長到2031年的156.7億美元，複合年成長率預計將成長12.80%。

神經刺激是一種使用植入式醫療設備來調節和改變神經活動的治療技術。此過程中使用的設備稱為神經刺激裝置，治療過程包括向大腦、周邊神經系統和脊髓的目標區域發送電脈衝。神經刺激對於治療帕金森氏症、癲癇、慢性疼痛和憂鬱症神經系統疾病特別有效。對於患有帕金森氏症和肌張力不全症疾病的患者，其症狀可能因長期壓力或社會限制而加劇，電刺激可以緩解症狀並提高生活品質。由於人口老化、先進技術的市場開拓、輔助性治療的使用增加以及偏頭痛和癲癇等慢性疾病的盛行率上升等因素，神經刺激設備的市場正在擴大。此外，大量未滿足的醫療需求、神經系統疾病負擔的增加、外部研究資金的獲取以及對微創手術的偏好正在推動市場成長。例如，中風和阿茲海默症是美國的主要原因，而帕金森氏症影響近100萬美國，每年新增病例超過6萬例。隨著這些疾病發病率的增加，對神經刺激設備的需求也預計會增加。製造商正在投資研究來推進這些技術，目標是提供侵入性較小的產品，從而縮短住院時間並加快康復時間。

市場概況
脊髓刺激
- 故障恢復綜合症
- 慢性疼痛
- 缺血
腦深部刺激
- 帕金森氏症
- 震顫
- 憂鬱症
- 其他
薦椎神經刺激
- 尿失禁
- 大便失禁
迷走神經刺激
- 癲癇
- 其他
胃電刺激
- 胃輕癱
- 肥胖
經皮神經電刺激
- 抗治療性憂鬱症
- 其他
經顱磁刺激
- 憂鬱症
- 偏頭痛
呼吸電刺激
- 脊髓損傷

神經刺激設備市場規模：按地區

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Medtronic（Ireland）
Abbott Laboratories（US）
Boston Scientific Corporation（US）
LivaNova PLC（UK）
Nevro Corp.（US）
NeuroPace, Inc.（US）
Synapse Biomedical Inc.（US）
Neuronetics, Inc.（US）
NDI Medical LLC（US）
Stimwave Technologies（US）
BioControl Medical（Israel）
EndoStim（US）
Aleva Neurotherapeutics（Switzerland）
SPR Therapeutics（US）
electroCore, Inc.（US）
Soterix Medical Inc.（US）
Cala Health（US）
Inspire Medical Systems, Inc.（US）
NeuroSigma, Inc.（US）
Autonomic Technologies Inc.（US）
Axonics Modulation Technologies, Inc.（US）
Nexstim Plc（Finland）

簡介目錄

Product Code: SQMIG35B2087

Global Neurostimulation Devices Market size was valued at USD 5.3 Billion in 2022 and is poised to grow from USD 5.98 Billion in 2023 to USD 15.67 Billion by 2031, at a CAGR of 12.80% during the forecast period (2024-2031).

Neurostimulation is a therapeutic technique that utilizes implantable medical devices to regulate and alter neural activity. The devices employed in this process are known as neurostimulators, and the therapy involves delivering electrical impulses to targeted regions of the brain, peripheral nervous system, or spinal cord. Neurostimulation is particularly effective in managing neurological disorders like Parkinson's disease, epilepsy, chronic pain, and depression. It works by providing electrical stimulation that can help alleviate symptoms and enhance the quality of life for patients with conditions such as Parkinson's disease or dystonia, who may experience worsened symptoms due to chronic stress and social restrictions. The market for neurostimulation devices is expanding due to several factors, including an aging population, the development of advanced technologies, increasing use as adjunctive therapy, and the rising prevalence of chronic conditions like migraines and epilepsy. Additionally, high unmet medical needs, the growing burden of neurological disorders, external research funding, and a preference for minimally invasive procedures are driving market growth. For instance, stroke and Alzheimer's disease are major causes of death in the U.S., with Parkinson's disease affecting nearly one million Americans and over 60,000 new cases annually. As the incidence of these diseases rises, the demand for neurostimulation devices is projected to grow. Manufacturers are investing in research to advance these technologies, aiming to offer products that are less invasive, leading to shorter hospital stays and quicker recovery times, which will further propel market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurostimulation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neurostimulation Devices Market Segmental Analysis

The Global Neurostimulation Devices market is segmented by type, Application, and region. Based on type, the market can be segmented into Internal Neuromosulation (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Electric Stimulator) External neuromodulation (Transcutaneous Electrical Nerve Stimulation (TENS), Transcranial Magnetic Stimulation (TMS), Respiratory Electrical Stimulation (RES)). Based on Application, the market is segmented into Spinal Cord Stimulation (Failed Back Syndrome, Chronic Pain, Ischemia), Deep Brain Stimulation (Parkinson's Disease, Tremor, Depression, Others), Sacral Nerve Stimulation (Urine Incontinence, Fecal Incontinence), Vagus Nerve Stimulation (VNS) (Epilepsy, Others), Gastric Electrical Stimulation (Gastroparesis, Obesity), Transcutaneous Electrical Nerve Stimulation (Treatment-resistant Depression, Others), Transcranial Magnetic Stimulation (Depression, Migraine Headache), Respiratory Electrical Stimulation (Spinal Cord Injury). Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Neurostimulation Devices Market

A major driver of the neurostimulation devices market is the escalating prevalence of neurological disorders globally. According to the World Health Organization, neurological conditions contribute significantly to the global disease burden, impacting millions of individuals. The rising incidence of disorders such as Parkinson's disease, epilepsy, and chronic pain is increasing the demand for neurostimulation devices, which offer effective treatment solutions. This growing need for advanced therapies is prompting manufacturers to invest heavily in research and development to create innovative neurostimulation devices. Such advancements are anticipated to further drive market expansion.

Restraints in the Global Neurostimulation Devices Market

Despite the increasing demand for neurostimulation devices, several factors are hindering market growth. One major restraint is the high cost of these devices, which poses a significant financial burden on patients, particularly in low- and middle-income countries. Additionally, the shortage of skilled healthcare professionals and the limited availability of neurostimulation devices in certain regions further restrict market expansion. Moreover, potential risks related to device implantation, such as infections and device malfunctions, also contribute to market challenges.

Market Trends of the Global Neurostimulation Devices Market

A prominent trend in the neurostimulation devices market is the advancement of minimally invasive and non-invasive technologies. These innovations are increasingly favored due to their benefits over traditional surgical methods, such as reduced pain, shorter hospital stays, and quicker recovery periods. Additionally, the emergence of wireless and implantable devices is contributing to market growth, as they enhance patient comfort by eliminating the need for external wires and bulky equipment. This shift towards less invasive neurostimulation solutions is anticipated to drive continued market expansion in the coming years.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors of The Market
Degree Of Competition
Top Investment Pockets
Market Attractive Index
Ecosystem Mapping
Technology Analysis
Cost Analysis
Market Trend Analysis
Competition Analysis
Supply chain analysis
Investment Analysis
Application-Specific Analysis
Patent analysis
Trade analysis
Case study analysis
Porter's five forces analysis

Global Neurostimulation Devices Market by Type

Market overview
Internal Neuromodulation
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Vagus Nerve Stimulation
- Sacral Nerve Stimulation
- Gastric Electrical Stimulation
External Neuromodulation
- Transcutaneous Electrical Nerve Stimulation (TENS)
- Transcranial Magnetic Stimulation (TMS)
- Respiratory Electrical Stimulation (RES)

Global Neurostimulation Devices Market by Application

Market Overview
Spinal Cord Stimulation Market
- Failed Back Syndrome
- Chronic Pain
- Ischemia
Deep Brain Stimulation Market
- Parkinson's Disease
- Tremor
- Depression
- Other DBS Applications
Sacral Nerve Stimulation Market
- Urine Incontinence
- Fecal Incontinence
Vagus Nerve Stimulation Market
- Epilepsy
- Other VNS Applications
Gastric Electrical Stimulation Market
- Gastroparesis
- Obesity
Transcutaneous Electrical Nerve Stimulation Market
- Treatment-resistant Depression
- Other TENS Applications
Transcranial Magnetic Stimulation Market
- Depression
- Migraine Headache
Respiratory Electrical Stimulation Market
- Spinal Cord Injury

Global Neurostimulation Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (U.K.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nevro Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeuroPace, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synapse Biomedical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neuronetics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NDI Medical LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stimwave Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioControl Medical (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EndoStim (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aleva Neurotherapeutics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SPR Therapeutics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
electroCore, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Soterix Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cala Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inspire Medical Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeuroSigma, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Autonomic Technologies Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Axonics Modulation Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nexstim Plc (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments